Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000137

Director sold 3,530 shares at an average $8.36 ($29,527)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Zoon Kathryn C Director 2023-05-25 Sale 10b5-1 −1,700 $8.38 $14,246 51,801 D
Zoon Kathryn C Director 2023-06-02 Sale 10b5-1 −1,830 $8.35 $15,281 49,971 D
Open-market sales · 3,530 sh · avg $8.36 · $29,527
Loading xslF345X05/wk-form4_1690201708.xml…